New advances in cancer therapy targeting TGF-β signaling pathways
Minyue Shou, Hanyu Zhou, Ling Ma · 2023
Read New advances in cancer therapy targeting TGF-β signaling pathways by Minyue Shou, Hanyu Zhou, Ling Ma (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10746361.txt.
Description
Minyue Shou, Hanyu Zhou, and Ling Ma review in this 2023 paper new cancer therapies that target the TGF-beta pathway. Tumors pour out this signal to mute the immune attack, and high levels track with poor outlook in many cancers. The review gives pride of place to a recent design: decoy receptors, built from the signal's own receptor, anchored to engineered T cells so they soak the signal up.
T cells with the decoy kept making attack signals and drained TGF-beta from their surroundings in lab work. The authors also survey other ways to block the path and the blocks that slow the field: the signal's dual role, toxicity risks, and thin dosing data. In-vivo proof for the decoy is still owed.
Catalog record
| CREATOR | Minyue Shou, Hanyu Zhou, Ling Ma |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |